Legal Representation
Attorney
Michael N. Mercanti
USPTO Deadlines
Next Deadline
In Grace Period
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20191105)
Due Date
November 05, 2025
Grace Period Ends
May 05, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 2, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 2, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 2, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Oct 7, 2025 | NA75 | E | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | Loading... |
| Oct 7, 2025 | C75A | O | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | Loading... |
| Sep 18, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Jun 12, 2025 | ES75 | I | TEAS SECTION 71 & 15 RECEIVED | Loading... |
| Feb 21, 2025 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Nov 5, 2024 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | Loading... |
| Mar 28, 2020 | COC. | O | CORRECTION UNDER SECTION 7 - PROCESSED | Loading... |
| Mar 23, 2020 | EROP | I | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | Loading... |
| Mar 21, 2020 | FINV | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Mar 5, 2020 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Mar 5, 2020 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Feb 13, 2020 | PRAM | O | POST REGISTRATION ACTION MAILED - SEC. 7 | Loading... |
| Feb 5, 2020 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Feb 5, 2020 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jan 6, 2020 | ES7R | I | TEAS SECTION 7 REQUEST RECEIVED | Loading... |
| Nov 5, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 20, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 20, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 16, 2019 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Jul 31, 2019 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Jul 31, 2019 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Jul 31, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 18, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 9, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 28, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 28, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 28, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 16, 2019 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Feb 22, 2019 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Feb 21, 2019 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Feb 15, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Feb 14, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 12, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 6, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 6, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 31, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Dietetic substances adapted for medical use, ophthalmologic preparations
Additional Information
Design Mark
The mark consists of the wording "EYEPHARMA" in blue capital letters. A stylized blue eye design appears to left of the wording "EYEPHARMA". A curved blue line appears to the left of the eye design and a second curved blue line appears above the eye design. A curved rainbow colored line appears below the eye design that features the colors purple, blue, green, yellow, orange and red. The color white represents background or transparent areas and is not part of the mark.
Color Claim
The color(s) purple, blue, green, yellow, orange and red is/are claimed as a feature of the mark.
Other
In the statement, in both lines 8 and 9, "EYEPHARM" should be deleted, and "EYEPHARMA" should be inserted.
Pseudo Mark
EYE PHARMACY
Classification
International Classes
005